OFM

Omega Fund Management Portfolio holdings

AUM $154M
This Quarter Return
+34.97%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$178M
AUM Growth
+$178M
Cap. Flow
-$23.2M
Cap. Flow %
-12.97%
Top 10 Hldgs %
99.49%
Holding
14
New
–
Increased
–
Reduced
2
Closed
2

Top Buys

No buys this quarter

Top Sells

1
MORF
Morphic Holding, Inc. Common Stock
MORF
$16.5M
2
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
$5.01M
3
REPL icon
Replimune Group
REPL
$1.13M
4
JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
$510K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
REPL icon
1
Replimune Group
REPL
$422M
$69.7M 39.05% 3,001,319 -48,868 -2% -$1.13M
NUVB icon
2
Nuvation Bio
NUVB
$1.02B
$27.1M 15.2% 15,072,340 – –
ALPN
3
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$20.9M 11.69% 2,029,580 – –
MORF
4
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$17.8M 9.95% 309,846 -287,877 -48% -$16.5M
IMA
5
ImageneBio, Inc. Common Stock
IMA
$150M
$14.8M 8.27% 2,249,123 – –
THRX
6
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$6.64M 3.72% 711,479 – –
KRON
7
DELISTED
Kronos Bio
KRON
$6.57M 3.68% 3,818,283 – –
SANA icon
8
Sana Biotechnology
SANA
$777M
$5.03M 2.82% 843,750 – –
SPRB
9
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
$4.65M 2.6% 2,161,022 – –
IMUX icon
10
Immunic
IMUX
$80.9M
$4.49M 2.51% 1,788,160 – –
SYRS
11
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$792K 0.44% 251,270 – –
SNTI icon
12
Senti Biosciences
SNTI
$38.5M
$123K 0.07% 195,792 – –
PRTK
13
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
– – -1,971,241 Closed -$5.01M
JNCE
14
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
– – -275,513 Closed -$510K